Also, Goldman Sachs recently added to the bearish outlook on Moderna, downgrading the stock to Hold and cutting its price target from $99 to $51, citing continued revenue guidance reductions and ...

Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for canceled manufacturing contract. Goldman Sachs US Biotechnology Analyst Salveen ...

This is a significant shift from the previous quarter when Moderna’s Q3 2024 results showcased resilience. Goldman Sachs Weighs in on Moderna Stock While Moderna’s Q4 earnings may represent a ...

Mutual of America Capital Management LLC trimmed its position in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 2.6% during the ...

Hedge funds unwound positions in single stocks on Friday at the largest amount in over two years, with some activity ...

Feb 17 (Reuters) - Goldman Sachs on Monday raised its year-end 2025 gold price forecast to $3,100 per ounce, up from $2,890, citing sustained central bank demand. The bank estimates that ...

“S&P 500 annual return dispersion in 2024 rose to 70 percentage points, the highest level outside of recessions since 2007,” David Kostin, strategist at Goldman Sachs ... 20.5 Moderna Inc ...